ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,371Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 2588

$1.5M Total Retail Price of All Prescriptions

Rank: 23 out of 2588

794 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 794 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 794 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 24,975 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 1,121 970 1 3
HYDROCODONE-ACETAMINOPHEN 1,115 853 S3 2 7
LEVOTHYROXINE SODIUM 1,087 957 3 2
AMLODIPINE BESYLATE 1,045 879 4 4
SIMVASTATIN 942 810 5 1
PRAVASTATIN SODIUM 904 793 6 16
FUROSEMIDE 889 849 7 5
OMEPRAZOLE 750 579 8 6
METOPROLOL TARTRATE 709 635 9 9
WARFARIN SODIUM 704 538 10 10
CARVEDILOL 530 473 11 20
POTASSIUM CHLORIDE 501 457 12 15
DONEPEZIL HCL 439 421 13 22
METFORMIN HCL 391 303 14 8
ATORVASTATIN CALCIUM 387 340 15 11
CITALOPRAM HBR 376 328 16 27
NAMENDA 373 359 17 32
HYDROCHLOROTHIAZIDE 354 266 18 13
METOPROLOL SUCCINATE 347 313 19 12
SPIRONOLACTONE 309 293 20 58
TRAMADOL HCL 302 277 21 19
ALLOPURINOL 283 254 22 33
LOSARTAN POTASSIUM 261 228 23 17
RANITIDINE HCL 259 168 24 37
MIRTAZAPINE 243 242 25 63
PANTOPRAZOLE SODIUM 241 214 26 28
GLIPIZIDE 230 190 27 44
GABAPENTIN 222 188 28 18
DILTIAZEM 24HR CD 222 197 28 98
SERTRALINE HCL 221 175 30 26
MELOXICAM 215 160 31 51
TAMSULOSIN HCL 205 194 32 23
CLOPIDOGREL 186 151 33 30
AZITHROMYCIN 183 146 34 45
CIPROFLOXACIN HCL 177 159 35 82
ISOSORBIDE MONONITRATE ER 175 171 36 49
DIOVAN 173 152 37 29
SPIRIVA 164 151 38 56
ATENOLOL 164 145 38 14
METFORMIN HCL ER 161 136 40 67
DIGOXIN 160 146 41 38
ESCITALOPRAM OXALATE 160 141 41 68
GLIMEPIRIDE 158 140 43 39
PLAVIX 156 139 44 43
ZOLPIDEM TARTRATE 155 127 45 24
CLONIDINE HCL 154 110 46 54
TRAZODONE HCL 153 109 47 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 140 47 35
CYMBALTA 149 124 49 70
TRIAMTERENE-HCTZ 143 135 50 46
POLYETHYLENE GLYCOL 3350 142 125 51 55
FLUTICASONE PROPIONATE 142 102 51 40
FENTANYL 139 133 S2 53 78
IPRATROPIUM-ALBUTEROL 132 129 54 104
INSULIN SYRINGE 129 118 55 81
KLOR-CON 10 124 115 56 75
FINASTERIDE 123 123 57 97
OXYBUTYNIN CHLORIDE 121 84 58 132
QUETIAPINE FUMARATE 118 99 59 74
ADVAIR DISKUS 118 108 59 48
LANTUS 116 109 61 47
PROAIR HFA 115 76 62 50
CRESTOR 115 100 62 25
ROPINIROLE HCL 112 83 64 113
VERAPAMIL ER 112 98 64 102
MEGESTROL ACETATE 111 109 R 66 169
AMOXICILLIN 110 82 67 130
ALENDRONATE SODIUM 107 107 68 21
AMITRIPTYLINE HCL 106 57 R 69 91
HYDRALAZINE HCL 105 86 70 53
CEPHALEXIN 104 88 71 138
FENOFIBRATE 99 50 72 64
PREDNISONE 97 86 73 42
GLIPIZIDE-METFORMIN 97 90 73 398
FELODIPINE ER 94 94 75 108
LEVETIRACETAM 93 62 76 90
ALBUTEROL SULFATE 90 88 77 116
LOVASTATIN 83 83 78 34
FAMOTIDINE 83 39 78 36
DILTIAZEM ER 81 71 80 150
DOXAZOSIN MESYLATE 80 80 81 96
COMBIVENT 80 70 81 145
AMLODIPINE BESYLATE-BENAZEPRIL 80 55 81 76
NEXIUM 76 52 84 41
MECLIZINE HCL 74 67 85 120
SINGULAIR 73 53 86 94
CELEBREX 71 71 87 99
OXYBUTYNIN CHLORIDE ER 70 37 88 85
NOVOLIN 70-30 69 54 89 244
GLIPIZIDE ER 68 67 90 73
LANTUS SOLOSTAR 67 58 91 93
MICARDIS 67 40 91 274
PROCHLORPERAZINE MALEATE 67 60 91 346
PHENYTOIN SODIUM EXTENDED 66 59 94 109
BENAZEPRIL HCL 66 56 94 84
TERAZOSIN HCL 64 64 96 137
CARBIDOPA-LEVODOPA 63 63 97 83
LEVEMIR FLEXPEN 60 60 98 220
EXELON 60 60 98 118
SYMBICORT 60 60 98 129
FOSINOPRIL SODIUM 60 60 98 212
LEVOFLOXACIN 59 51 102 77
TRICOR 59 48 102 122
LYRICA 58 44 104 100
BACLOFEN 58 32 104 142
LEXAPRO 56 53 106 182
HYDROXYZINE HCL 56 47 R 106 194
METOCLOPRAMIDE HCL 56 56 106 136
MONTELUKAST SODIUM 56 46 106 153
TORSEMIDE 55 55 110 133
TRIAMCINOLONE ACETONIDE 54 36 111 106
RISPERIDONE 53 40 112 57
LEVEMIR 53 50 112 206
FLUCONAZOLE 53 49 112 277
NIASPAN 52 52 115 115
KLOR-CON M20 52 51 115 52
NOVOLOG MIX 70-30 52 51 115 271
QUINAPRIL HCL 50 38 118 148
PROPRANOLOL HCL 50 40 118 128
ABILIFY 50 50 118 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.